Best practices in preventing heartbreak:

A look at a SWOG cancer control trial

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The development of more effective cancer treatment has yielded higher cure rates, longer survival, and a decrease in cancer recurrence. As of January 2019, the National Cancer Institute estimated that there were 16.9 million cancer survivors in the United States. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Justin Floyd, DO, FACOI
Medical oncologist, Cancer Care Specialists of Illinois, Heartland NCORP
Monika Leja, MD
Clinical assistant professor, Frankel Cardiovascular Center, University of Michigan
Table of Contents

YOU MAY BE INTERESTED IN

Justin Floyd, DO, FACOI
Medical oncologist, Cancer Care Specialists of Illinois, Heartland NCORP
Monika Leja, MD
Clinical assistant professor, Frankel Cardiovascular Center, University of Michigan

Can you spare 10 minutes to complete a survey?

Your feedback is really important—you're helping us shape our coverage priorities and services to better serve you, our readers.

Login